Envafolimab, Lenvatinib Combined With VP-16 in Platinum-resistant Recurrent Epithelial Ovarian Cancer

Clinical trial NCT05422183 · UNKNOWN

Trial details

NCT number: NCT05422183
Sponsor: Zhongda Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer, Epithelial

Start date: 2022-06-30
Primary completion: 2022-12-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.